DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 017618
The generic ingredient in BRICANYL is terbutaline sulfate. There are seven drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the terbutaline sulfate profile page.
Summary for 017618
Tradename: | BRICANYL |
Applicant: | Sanofi Aventis Us |
Ingredient: | terbutaline sulfate |
Patents: | 0 |
Therapeutic Class: | Respiratory Tract Agents |
Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 017618
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 2.5MG | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No |
Expired US Patents for NDA 017618
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Sanofi Aventis Us | BRICANYL | terbutaline sulfate | TABLET;ORAL | 017618-002 | Approved Prior to Jan 1, 1982 | ➤ Try a Free Trial | ➤ Try a Free Trial |
Sanofi Aventis Us | BRICANYL | terbutaline sulfate | TABLET;ORAL | 017618-002 | Approved Prior to Jan 1, 1982 | ➤ Try a Free Trial | ➤ Try a Free Trial |
Sanofi Aventis Us | BRICANYL | terbutaline sulfate | TABLET;ORAL | 017618-001 | Approved Prior to Jan 1, 1982 | ➤ Try a Free Trial | ➤ Try a Free Trial |
Sanofi Aventis Us | BRICANYL | terbutaline sulfate | TABLET;ORAL | 017618-001 | Approved Prior to Jan 1, 1982 | ➤ Try a Free Trial | ➤ Try a Free Trial |
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
Complete Access Available with Subscription